Bimatoprost
SPON 1266-14
Approved small_molecule completed
Quick answer
Bimatoprost for Graves' Ophthalmopathy is a Approved program (small_molecule) at Cardiff Oncology with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Cardiff Oncology
- Indication
- Graves' Ophthalmopathy
- Phase
- Approved
- Modality
- small_molecule
- Status
- completed